Loading…
← CockpitCompetitor Analysis › AHG Akso Health Group Sponsored ADROpen in the cockpit ↗

Akso Health Group Sponsored ADRAHGCompetitor analysis, valuation and peers

United States · USD·Consumer Discretionary›Internet Retail
Momentum neutral 44
Mkt cap
$1.14B
US dollars, full cap
$/day
$17,417
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-8.1 pp
WACC 6.4%
Hurdle
n/a
no reverse DCF
Next earnings
26 days
2 Dec 2026
Close · USD$1.35
1D+4.2%
1W+7.1%
1M+18.4%
3M0.0%
6M-34.1%
YTD-17.7%
1Y-16.7%
ATR %8.9%
Beta0.13
52w lowhigh46.0% off high

What Akso Health Group Sponsored ADR does

Employees: 12

Akso Health Group Sponsored ADR at a glance

Size Akso Health Group Sponsored ADR (AHG) is a United States Consumer Discretionary company (Internet Retail) with a market value of $1.14B, the 2169th largest of 3,117 United States companies the cockpit tracks. Shares closed at $1.35 on 6 Nov 2026.

Performance Over six months the shares fell 34.1%, against +5.7% for the median peer and -1.1% for the United States market (cap-weighted) — lowest of 21 in its peer set.

Growth Revenue fell 6.2% over the last twelve months (peer median +3.6%); the operating margin is -28.9% (peer median 3.4%).

Valuation It trades at 82.3× enterprise value to sales against a peer median of 1.1× (most expensive of 21).

Capital Return on invested capital runs 8.1 points below its cost of capital (6.4% WACC).

Next results Next results expected around 2 Dec 2026 (exchange calendar; dates can move).

Relative performance

507510011 May 202611 Aug 20266 Nov 2026Peer median 105AHG 68
Six months, rebased to 100: Akso Health Group Sponsored ADR against the median of its 20 peers (local-currency closes).

Akso Health Group Sponsored ADR financials

Reported figures in USD; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$13.9M$13.9M$14.8M$2.41M$13.1M
Revenue growth—-6%+514%-82%—
Gross profit-$1.16M-$2.39M-$281,859$121,910$1.26M
EBITDA-$1.63M-$1.63M-$1.78M-$8.62M-$14.2M
Net income-$18.7M-$18.7M-$135M-$9.05M-$1.36M
Free cash flow-$12.8M-$12.8M$1.02M$1.35M-$3.24M
Capital expenditure$1,645$1,644$154,643$0$0
Total debtn/a$2.38M$2.08M$0$0

Quarterly statements and history in the cockpit →

Akso Health Group Sponsored ADR competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-25%0%+25%+50%0%+20%MANYAVAR002127003010RVLVINDIAMART300592LQDTLUXETHGWOOF300792REAL002640GICAO2678601113ASCGRPNAHG6-month return →1-month return →
Up and to the right = strong over both horizons. Akso Health Group Sponsored ADR is the large dot.

Fundamentals: revenue growth against valuation

-25%0%+25%+50%+75%0×25×50×75×MANYAVAR002127003010RVLVINDIAMART300592LQDTLUXEWOOFREAL0026402678AHGRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Akso Health Group Sponsored ADR is the large dot.

Akso Health Group Sponsored ADR competitors and peer comparison

How Akso Health Group Sponsored ADR compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Akso Health Group Sponsored ADR against its 20 peers (data as of 6 Nov 2026)
MeasureAHGPeer medianRank in peer set
1-month return+18.4%-1.1%4th highest of 21
6-month return-34.1%+5.7%lowest of 21
Distance from 52-week high-46.0%-25.2%3rd lowest of 21
Revenue growth (TTM)-6.2%+3.6%6th lowest of 21
Operating margin-28.9%3.4%lowest of 21
EV / Sales82.3×1.1×most expensive of 21
ROIC minus cost of capital-8.1 pp-2.4 pp6th lowest of 16

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Akso Health Group Sponsored ADR AHGUnited States$1.14B-34%-6%-29%82.3×n/an/a
Vedant Fashions MANYAVAR.NSIndia$1.22B+6%+2%32%7.9×21.4%+21.5%
NanJi E-Commerce 002127.SZChina$1.05B-1%-28%-12%2.3×6.4%-9.0%
Guangzhou Ruoyuchen Technology 003010.SZChina$1.31B-8%+75%10%1.9×1.7%+24.7%
Revolve RVLVUnited States$1.32B-11%+15%6%0.8×n/an/a
IndiaMART InterMESH INDIAMART.NSIndia$985M-26%+12%34%3.8×8.2%+18.6%
Huakai Yibai Technology 300592.SZChina$966M+27%-11%7%0.8×3.4%+132.3%
Liquidity Services LQDTUnited States$1.37B+21%+5%9%2.4×16.2%+18.3%
LuxExperience B.V. Sponsored ADR LUXEUnited States$1.40B+20%+111%-6%0.4×n/an/a
THG THG.LUnited Kingdom$877M+30%+10%-1%0.7×n/an/a
Petco Health & Wellness WOOFUnited States$848M+5%-1%3%0.6×6.6%+3.9%
Hangzhou Onechance Tech Crop 300792.SZChina$839M-32%-19%9%4.3×19.9%-3.7%
Aucnet 3964.TJapan$824M+12%+12%15%1.5×0.1%+21.6%
RealReal REALUnited States$1.61B+25%+18%0%2.5×n/an/a
Global Top E-Commerce 002640.SZChina$757M-12%-6%1%0.9×33.4%-19.8%
Global Industrial GICUnited States$1.77B+59%+10%8%1.2×1.3%+6.0%
AO World AO..LUnited Kingdom$687M+6%+11%4%0.4×3.0%-5.3%
ASKUL 2678.TJapan$682M+2%-20%-5%0.3×n/an/a
Yiwu Huading Nylon 601113.SSChina$670M-28%-5%1%1.0×n/an/a
ASOS ASC.LUnited Kingdom$670M+88%-15%-1%0.5×1.2%-5.5%
Groupon GRPNUnited States$630M-13%+2%2%1.4×27.5%-18.9%

Questions

Which companies are Akso Health Group Sponsored ADR's closest peers?
The cockpit's peer set: Vedant Fashions (MANYAVAR.NS), NanJi E-Commerce (002127.SZ), Guangzhou Ruoyuchen Technology (003010.SZ), Revolve (RVLV), IndiaMART InterMESH (INDIAMART.NS), Huakai Yibai Technology (300592.SZ), Liquidity Services (LQDT), LuxExperience B.V. Sponsored ADR (LUXE).
Is Akso Health Group Sponsored ADR expensive compared with its peers?
On ev / sales it trades at 82.3× against a peer median of 1.1×, most expensive of 21 in its peer set.
How has Akso Health Group Sponsored ADR stock performed?
Over six months to 6 Nov 2026 the shares returned -34.1% against +5.7% for the median peer; over one year -16.7%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.